Novo Nordisk is gearing up to submit its rare blood disorder drug to the FDA after the former Forma Therapeutics asset ...
Please provide your email address to receive an email when new articles are posted on . Ninety percent of patients with sickle cell disease survived at least 7 years after allogeneic HCT. A majority ...
This article is part of a Health Affairs Forefront series on “The Future of Sickle Cell Disease Research and Care” with support from the American Society of Hematology. The articles in the series are ...
SAN DIEGO — Significant complications were common in female patients with sickle cell disease (SCD) who underwent fertility preservation (FP) procedures, and 13% required multiple retrieval cycles, a ...
Zacks Investment Research on MSN
NVO's etavopivat hits key goals in phase III sickle cell disease study
Novo Nordisk NVO announced meeting both co-primary endpoints in a late-stage study of its investigational candidate, etavopivat, for adults and adolescents with sickle cell disease (SCD). The data ...
A Cherokee County man says he has been successfully cured of Sickle Cell Anemia complications. Kyle Registre, 23, joined a Children's Healthcare of Atlanta gene therapy clinical trial in 2019 Registre ...
Sickle cell disease can lead to a severe complication known as acute chest syndrome (ACS), but the underlying mechanisms are not well understood. A new study by Mass General Brigham investigators ...
Makenzie’s first sickle cell pain crisis came without warning. She was scared and felt alone. Not only was the pain excruciating, but her parents weren’t there—her two worst fears at once. She spent ...
OMAHA, Neb. (WOWT) - Nobel Prize-winning technology offers a potential cure for sickle cell disease. Simply put, doctors can edit a patient’s genes to alter blood cells. But this gene editing ...
RICHMOND, Va. — September is National Sickle Cell Awareness Month. Sickle cell affects 100,000 people in the United States, primarily impacting African Americans. To learn more about the genetic blood ...
Sickle cell disease advocates in East Texas say raising awareness and expanding education are critical steps toward improving care and saving lives. Despite being the most common inherited blood ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results